Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid’s Shares Rise 15 Percent

Shares of Cepheid rose 15 percent for the five-day trading period ended Tuesday. The stock led the 18 firms that gained ground during a strong week for the BCW Index and the stock market in general.
 
Illumina’s shares rose 9.7 percent, Qiagen’s rose 9 percent, and Affymetrix’s shares climbed 8.8 percent for the week.
 
Only three firms posted declines for the week, with Sequenom’s stock falling the most at 4.3 percent.
 

Overall, the Index was up 2.6 percent for the week, matching the gains for the Dow Jones Industrial Average. The Nasdaq rose 3 percent, and the Nasdaq Biotech Index closed up 2 percent for the tracking period.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(June 19, 2007)
Starting Price
(
June 12, 2007)
% change
Affymetrix
AFFX
26.85
24.69
8.75
Agilent
A
39.31
37.47
4.91
Applied Biosystems
ABI
28.70
28.48
0.77
Beckman
BEC
66.76
67.16
-0.60
Becton Dickinson
BDX
75.34
74.44
1.21
Bio-Rad
BIO
74.04
73.68
0.49
Bruker
BRKR
9.24
9.15
0.98
Caliper
CALP
4.39
4.21
4.28
Cepheid
CPHD
13.06
11.36
14.96
Illumina
ILMN
40.54
36.96
9.69
Invitrogen
IVGN
73.96
73.82
0.19
Luminex
LMNX
12.56
11.92
5.37
MDS
MDZ
20.48
19.72
3.85
Millipore
MIL
77.30
74.44
3.84
PerkinElmer
PKI
26.66
26.36
1.14
Qiagen
QGEN
18.14
16.65
8.95
Sequenom
SQNM
4.50
4.70
-4.26
Sigma-Aldrich
SIAL
42.49
41.12
3.33
Thermo
TMO
53.40
51.44
3.81
Third Wave
TWTI
5.42
5.54
-2.17
Waters
WAT
60.44
60.53
-0.15
BCW Index Average
36.84
35.90
2.62
The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.